Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Phase 2 study of breakthrough vaccine against Toxic Shock Syndrome successfully completed

· Phase 2 studies showed the TSS1-T vaccine to be safe and effective, offering potential preventative therapy for vulnerable groups and medical workers · Outcome is also a major step in the battle against MRSA infections · Phase 3 trial preparation underway · Staphylococcal-induced Toxic Shock Syndrome (TSS) is a serious and life-threatening condition affecting at risk patients, including those with compromised immunity and premenopausal women · Methicillin-resistant Staphylococcus aureus (MRSA) is a constant threat to patients and a major financial burden for healthcare

Polygiene Group invites you to a presentation of the fourth quarter 2022

Polygiene Group will publish its quarterly report for the fourth quarter (October-December) on February 16, 2023, at 8.00 CET. In connection to the announcement, Polygiene Group invites you to a video conference on the same day at 10.00 CET.· Presentation of the quarterly report, CEO Ulrika Björk · Review of the financial results, CFO Niklas Blomstedt The conference is expected to last 45 minutes and will be held in English. Registration is made via the link below no later than February 15, 2023. Instructions regarding access to the conference will be sent out via e-mail when you

Riksbank raises policy rate by 0.5 percentage points and, starting in April, will begin selling government bonds

Inflation is far too high and has continued to rise. For inflation to fall and stabilise around the target within a reasonable time, the Executive Board has decided to raise the Riksbank's policy rate by 0.5 percentage points to 3.0 per cent. The policy rate will probably be raised further during the spring. Further, the Executive Board decided that the Riksbank will, with effect from April, sell government bonds to reduce asset holdings at a faster pace.High global inflation and rising policy rates Central banks around the world have rapidly raised their policy rates to bring down

SpareBank1 SR-Bank: Buy-back of Tier 2: SRBANK22 and SRBANK27 PRO

SpareBank1 SR-Bank has bought back NOK 527 million in its Tier 2 bond issue with ticker SRBANK22 (ISIN: NO0010792476) at a cash price of 100.193. There remains NOK 98 million in bonds outstanding in the market after the buy-back. SpareBank1 SR-Bank has bought back NOK 227 million in its Tier 2 bond issue with ticker SRBANK27 PRO (ISIN: NO0010832421) at a cash price of 100.338. There remains NOK 73 million in bonds outstanding in the market after the buy-back. Settlement date 15 February 2023.

The Swedish Companies Registration Office has registered shares issued by OmniCar Holding AB on 29 December 2022

The Swedish Companies Registration Office has registered 17,483,333 shares issued by OmniCar Holding AB (“OmniCar”) on 29 December 2022. As a result, OmniCar’s number of shares increased from 77,867,328 to 95,350,661 and the share capital increased with SEK 1,748,333.3 from SEK 7,786,732.8 to SEK 9,535,066.10. SEK 10,489,999.8 has been paid for the issued and registered shares.In total, the Board of Directors of OmniCar resolved to issue 28,175,000 shares (with an aggregate subscription price of SEK 16,905,000) on 29 December 2022, of which 17,483,333 shares (SEK 10,489,999.8) now have been

Correction: Ambea year end report 2022

The correction refers to missing the word adjusted in the bullet points four in the summary of the fourth quarter (October – December) and full year (January – December) 2022. The correction only applies to the English version. Corrected press release and year-end report follows in its entirety.CEO comment: Strong organic growth continued in the fourth quarter, and our Swedish divisions, Nytida and Vardaga, showed stable underlying earnings, while the strategic shift in Klara generated results. Klara is now making a greater contribution to consolidated earnings, which was evident

UNION therapeutics announces full-year results for 2022 and provides business update

Hellerup, Denmark, February 9, 2023, – UNION therapeutics A/S (“UNION”), a privately held, multi-asset, clinical stage, pharmaceutical development company focused on immunology and infectious disease, announces full-year results for the period January 1 to December 31, 2022. 2022 has been a year of great progress for UNION with several important achievements paving the way for a very exciting 2023, including positive topline results from the Phase 2b study with oral orismilast in psoriasis, advancement of our mid- to late-stage clinical programs with orismilast and niclosamide,

CampX by Volvo Group opens new Incubator track for startups to accelerate sustainable mobility innovations

More than 50 startups have developed their ideas at CampX, the global collaboration hub for innovations by Volvo Group. The concept gives promising startups a physical place to explore and accelerate new ideas together with Volvo Group using an entrepreneurial mindset. Now, Volvo Group is taking the next step by adding a new track called Incubator where early-stage startups are invited to further develop innovations.CampX  by Volvo Group is a global collaboration hub for

Year-End Report, 1 January–31 December 2022

Successful sales strengthen results Photo: Stena Bulk Total incomeQ4: SEK 263.0 (151.2) millionFull year: SEK 686.1 (704.8) millionEBITDAQ4: SEK 203.7 (36.6) millionFull year: SEK 374.1 (–82.6) millionResult before taxQ4: SEK 142.8 (–308.2) millionFull year: SEK 126.1 (–658.2) million Result per share after taxQ4: SEK 2.95 (–6.45)Full year: SEK 2.58 (–13.84) Events in the third quarter · Strong result due to vessel sales. Result for Q4 2021 negatively affected by impairment of SEK 267.7 million. · Delivery of the sold vessels Stena Primorsk and

Outokumpu – Notice to the Annual General Meeting 2023

Outokumpu OyjStock exchange releaseFebruary 9, 2023 at 10.00 am EETOutokumpu – Notice to the Annual General Meeting 2023 Notice is given to the shareholders of Outokumpu Oyj (“Outokumpu” or “Company”) to the Annual General Meeting to be held on Thursday, March 30, 2023 at 1.00 pm EEST at Dipoli congress center in Otaniemi, at the address Otakaari 24, 02150 Espoo, Finland, entrance through the Gala entrance (Juhlaovi). The reception of persons who have registered for the meeting and the distribution of voting tickets will commence at 11.00 am EEST at the meeting venue.

Anders Jonson leaves Quickbit. Daniel Sonesson appointed acting CEO

This morning Quickbit’s Board of Directors and Anders Jonson have agreed to change the acting CEO for Quickbit. The board has appointed Daniel Sonesson as acting CEO.Anders Jonson leaves Quickbit and his role as acting CEO and Chief Operating Officer. During the notice period, Anders Jonson will be available to the new acting CEO and the board to ensure that the transition is as smooth as possible. The board is grateful that Anders Jonson has managed the business during a busy time and secured important components for the company. Anders Jonson stepped into his CEO role when the previous

UPM Biochemicals and HAERTOL Chemie GmbH announce strategic partnership to develop new sustainable coolants

UPM_Haertol_Image_Frostox [UPM Biochemicals and HAERTOL will jointly launch a new range of carbon-neutral engine and battery coolants that will help automakers reduce their carbon footprint.] UPM Biochemicals and HAERTOL will jointly launch a new range of carbon-neutral engine and battery coolants that will help automakers reduce their carbon footprint. (UPM, Helsinki, 9 February 2023 at 10:00 EET) – UPM Biochemicals  and HAERTOL Chemie GmbH  announced a development partnership today that will accelerate the introduction of

AFRY and Ringhals AB, owned by Vattenfall, in a pilot project for new forms of collaborations

The nuclear power industry is entering a phase in which the specialised competencies need to be secured long term. This affects strategies for the provision of expertise, personnel and cooperation with suppliers. To address these issues, Ringhals AB, has chosen AFRY as their trusted partner to carry out a pilot project at their nuclear power plant to modernise the control equipment for the waste facility, where existing ways of working are reviewed and further developed.With this pilot project, Vattenfall and AFRY are challenging existing ways of working with the aim of adding value by

SmartCraft ASA (SMCRT) - Invitation to presentation of fourth quarter 2022 results

SmartCraft ASA | Non-regulatory press releases9 February 2023 - SmartCraft ASA will publish its fourth quarter 2022 financial report on Wednesday 15 February 2023 at 07:00 CET together with the Q4 2022 presentation material on the company website and www.newsweb.no. Investors, analysts, and journalists are welcome to join to an English language webcast presentation of the report on the same day, Wednesday 15 February 2023, at 08:00 CET. Webcast link: https://channel.royalcast.com/landingpage/hegnarmedia/20230215_1/ Presenters: · Chief Executive Officer Gustav Line ·

Year-end Report 2022

Fourth quarter 2022 · Net sales increased to SEK 3,780m (3,509) corresponding to organic sales growth of 2% (2). · Operating profit, excl. items affecting comparability, decreased to SEK 25m (238),corresponding to an operating margin of 0.7% (6.8). · Operating profit includes items affecting comparability of SEK -156m (0). · Profit after tax amounted to SEK -166m (146), corresponding to earningsper share after dilution of SEK -0.98 (0.87). · Operating cash flow amounted to SEK -81m (-2), including a temporarily high amount ofinvestments in fixed assets due to the

ExpreS2ion announces financial results for the fourth quarter and full-year 2022

Hørsholm, Denmark, February 9, 2023– ExpreS2ion Biotech Holding AB (“ExpreS2ion”) today announces its fourth quarter and full-year financial results for 2022. The report is available as an attachment and on ExpreS2ion's website (www.expres2ionbio.com). Below is a summary of the report.CEO Bent U. Frandsen comments “In 2022, ExpreS[2]ion continued its journey towards becoming a stronger and more pipeline-driven biotechnology company with several high-value assets. Excellent progress was achieved in our leading development projects for COVID-19 and breast cancer, and our ExpreS2™ platform

Q4 Report 2022 – invitation to conference call and audiocast

Stockholm, February 9, 2023 - On Thursday, February 16, at 16.00 CET, IRRAS will host a conference call and an online presentation of its Q4 2022 interim report (which will have been published earlier on February 16 at 08.00 CET). The presentation will be held in English. Dial-in number to the teleconference will be received by registering on the link below. After the registration you will be provided phone numbers and a conference ID to access the conference: https://conference.financialhearings.com/teleconference/?id=5005418 The presentation will be webcast and can be accessed

Dr Azad Najar Keynote Speaker at the Opening of the AI Congress in Cairo

Press Release 09 February, 2023 Realheart's founder, innovator and now medical director, Azad Najar, had the honor of presenting the company's artificial heart as keynote speaker at a congress in Cairo early this year. The congress had Artificial Intelligence (AI) as its main theme and was organized by the Ministry of Youth and Sports.“We are delighted that knowledge of our artificial heart has reached so many parts of the world, especially the Middle East, where very few heart transplants are performed, so almost all heart failure patients, regardless of age, die from the disease. The

Veg of Lund enter Germany with partner distributor

In line with updated commercial strategy Veg of Lund now start addressing the German market through a distributor business model. Regional partner CCP AG will, starting immediately, address food manufacturing, cafés, and retail chains with the European patented DUG potato drink."The agreement with CCP AG marks the start of the updated business model where distributor and license partnerships will be cornerstones for the company growth moving forward. I look forward to having experienced and dedicated resources on the ground in Germany, supplied by our newly appointed German contractor”,

Year end report 2022

Increased turnover and operating profit. Proposed dividend 4.50 SEK/share (3.50). October - December 2022 · Net turnover 389.7 MSEK (319.9) · Operating profit EBITA 52.2 MSEK (43.3) · Operating margin EBITA 13.4% (13.5) · Operating profit EBIT 50.5 MSEK (42.4) · Operating margin EBIT 13.0% (13.2) · Profit after tax 35.9 MSEK (37.8) · Earnings per share before dilution 2.74 SEK (3.05) · Earnings per share after dilution 2.66 SEK (3.05) January - December 2022 · Net turnover 1,324.0 MSEK (1,186.9) · Operating profit EBITA 164.5 MSEK (136.8)

Teleste share-based long-term incentive programs 2023

Teleste CorporationStock Exchange ReleaseFebruary 9, 2023, at 9:30 a.m. EET   TELESTE SHARE-BASED LONG-TERM INCENTIVE PROGRAMS 2023   The Board of Directors of Teleste Corporation established a share-based incentive program in 2022 including three share-based incentive plans (LTI 2022 Program) for the key employees of Teleste. The key terms of the LTI Program were published by a stock exchange release on 10 February 2022. The Board of Directors has approved approximately 33 key employees as eligible for participating in the LTI Program in 2023. Matching Share Plan

Transcom Holding AB (publ): Invitation to Transcom fourth quarter 2022 results presentation webcast

Transcom are pleased to invite you to their Q4 2022 financial update webcast on Thursday, February 23, at 9:00 am CET, following the release of Q4 2022 results at 8:00 am CET. The Q4 report and presentation will be available on https://www.transcom.com/global/about-us/investor-relations. Representing Transcom Jonas Dahlberg, President & CEOSnejana Koleva, CFO Presentation details Date/Time: Thursday, February 23, at 9:00 am CET Online Registration link: https://app.livestorm.co/transcom-holding/transcom-holding-ab-q4-2022-results-presentation Important note: Please

Invitation to presentation of year-end report 2022 for Truecaller AB (publ)

Truecaller, the leading global platform for verifying contacts and blocking unwanted communication, is publishing its year-end report for 2022 on Wednesday 22 February 2023 at 07.30 CET.Alan Mamedi, CEO and Odd Bolin, CFO presents the report and answers questions in a webcast and conference call at 13.00 CET the same day. The presentation will be held in English.   Follow the presentation live: Link to webcast  To listen to the presentation by phone, please call:   SE: +468 505 163 86UK: +44 20 319 848

Repurchase of Outokumpu’s own shares

Outokumpu OyjStock exchange releaseFebruary 9, 2023, at 9.15 am EETRepurchase of Outokumpu’s own shares On February 8, 2023, Outokumpu has completed repurchases its own shares as follows (ISIN FI0009002422): +-------+----------------+------------------------------------+----------------+|Trading|Number of shares|Weighted average price / share, EUR*|Total cost, EUR*||venue | | | |+-------+----------------+------------------------------------+----------------+|CEUX |17,094 |5.0888

There are no items matching the current filter
There are no more items matching the current filter
Back to top